Lifeline for HAE patients: study offers continued access to promising drug
NCT ID NCT04933721
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study provides ongoing access to berotralstat for up to 139 people with hereditary angioedema (HAE) who previously took part in berotralstat trials. The main goal is to monitor safety and side effects over time. Participants take the medication daily to help control their condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study Center
Ottawa, Canada
-
Study Center
Brno, Czechia
-
Study Center
Pilsen, Czechia
-
Study Center
Grenoble, France
-
Study Center
Marseille, France
-
Study Center
Paris, France
-
Study Center
Frankfurt, Germany
-
Study Center
Skopje, North Macedonia
-
Study Center
Krakow, Poland
-
Study Center
Martin, Slovakia
-
Study Center
Cape Town, South Africa
-
Study Center
Daegu, South Korea
-
Study Center
Gwangju, South Korea
-
Study Center
Seoul, South Korea
-
Study Center
Madrid, Spain
-
Study Center
Bristol, United Kingdom
Conditions
Explore the condition pages connected to this study.